Abstract
Application of PLGA NSs for drug-eluting medical devices and mixed suspension, mixed product removal (MSMPR) crystallizers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., Kolodgie, F.D.: Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious? Circulation. 109(6), 701–705 (2004)
Joner, M., Finn, A.V., Farb, A., Mont, E.K., Kolodgie, F.D., Ladich, E., Virmani, R.: Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 48(1), 193–202 (2006)
Nordmann, A.J., Briel, M., Bucher, H.C.: Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur. Heart J. 27(23), 2784–2814 (2006)
Nakano, K., Egashira, K., Masuda, S., Funakoshi, K., Zhao, G., Kimura, S., Matoba, T., Sueishi, K., Endo, Y., Kawashima, Y., Hara, K., Tsujimoto, H., Tominaga, R., Sunagawa, K.: Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology. J. Am. Coll. Cardiol. Intv. 2(4), 277–283 (2009)
Tsukada, Y., Hara, K., Bando, Y., Tsujimoto, H.: Development of PLGA nanoparticles-coated stents. Funtai Gijutsu. 1(12), 53–59 (2009)
Tsukada, Y., Tsujimoto, H., Yamamoto, H., Kawashima, Y.: Development of drug-eluting stent coated with PLGA nanoparticles. Chem. Ind. 63(7), 52–58 (2012)
AnGes MG, Inc., Medikit Co. Ltd. and Hosokawa Micron Corporation, Press Release, http://www.anges-mg.com/news/pdf/081104.pdf. November 4, 2008
AnGes MG, Inc., Medikit Co. Ltd. and Hosokawa Micron Corporation, Press Release, http://www.anges-mg.com/news/pdf/20120328.pdf. March 28, 2012
Miyake, T., Ihara, S., Nakagami, H., Morishita, R.: Prevention of neointimal formation after angioplasty using Nf-Kappab decoy oligodeoxynucleotide-coated balloon catheter in rabbit model. J. Hypertens. 30, e277–e278 (2012)
Yoshimura, S., Morishita, R., Hayashi, K., Yamamoto, K., Nakagami, H., Kaneda, Y., Ogihara, T.: Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kappaB binding site as a novel molecular strategy. Gene Ther. 8(21), 1635–1642 (2001)
Takeuchi, K., Itoh, H., Yonemitsu, Y., Matsumoto, T., Kume, M., Komori, K., Maehara, Y.: In vivo reduction of the nuclear factor-κB activity using synthetic cis-element decoy oligonucleotides suppresses intimal hyperplasia in the injured carotid arteries in rabbits. Surg. Today. 37(7), 575–583 (2007)
Ohtani, K., Egashira, K., Nakano, K., Zhao, G., Funakoshi, K., Ihara, Y., Sunagawa, K.: Stent-based local delivery of nuclear factor-κB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits. Circulation. 114(25), 2773–2779 (2006)
Miyake, T., Aoki, M., Shiraya, S., Tanemoto, K., Ogihara, T., Kaneda, Y., Morishita, R.: Inhibitory effects of NFκB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J. Mol. Cell. Cardiol. 41(3), 431–440 (2006)
Yamasaki, K., Asai, T., Shimizu, M., Aoki, M., Hashiya, N., Sakonjo, H., Morishita, R.: Inhibition of NFκB activation using cis-element ‘decoy’of NFκB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gene Ther. 10(4), 356–364 (2003)
Shimizu, N., Azuma, N., Nishikawa, T., Hirata, S., Morishita, R., Kaneda, Y., Sasajima, T.: Effect on vein graft intimal hyperplasia of nuclear factor-kB decoy transfection using the second generation of HVJ vector. J. Cardiovasc. Surg. 48(4), 463–470 (2007)
Miyake, T., Ihara, S., Nakagami, H., Morishita, R.: Prevention of neointimal formation after angioplasty using Nf-Kappab decoy oligodeoxynucleotide-coated balloon catheter in rabbit model. J. Hypertens. 30, e277–e278 (2012)
Alvarez, A.J., Myerson, A.S.: Continuous plug flow crystallization of pharmaceutical compounds. Cryst. Growth Des. 10, 2219–2228 (2010)
Eder, R.J.P., Schmitt, E.K., Grill, J., Radl, S., Gruber Woeltfler, H., Khinast, J.D.: Seed loading effects on the mean crystal size of acetylsalicylic acid in a continuous flow crystallization device. Cryst. Res. Technol. 46, A227–A237 (2011)
Tahara, K., O’Mahony, M., Myerson, A.S.: Continuous spherical crystallization of albuterol sulfated with solvent recycle system. Cryst. Growth Des. 15, 5140–5156 (2015)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kawashima, Y. (2019). Future Perspectives of PLGA Nanospheres for Advanced DDSs and Continuous Preparation Systems for Spherical Crystallizers. In: Spherical Crystallization as a New Platform for Particle Design Engineering. Springer, Singapore. https://doi.org/10.1007/978-981-13-6786-1_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-6786-1_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6785-4
Online ISBN: 978-981-13-6786-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)